UCSF’s Alzheimer’s Disease Neuroimaging Initiative, the world’s largest observational study on Alzheimer’s disease, is pioneering the use of amyloid PET imaging as a diagnostic biomarker for a disease that afflicts over 5 million Americans.

When pain is precisely diagnosed and localized, we can treat it selectively. Through research and patient feedback, we're working to combat pain. 

PET/MRI is a hybrid imaging technology that is serving critical diagnostic and treatment purposes for current UCSF patients as well as playing an important role in research for future patients.

Our research with advanced imaging aims to help the children suffering from juvenile arthritis that we are treating today, as well as children in the future.

A popular radio personality in San Francisco reported on having brain surgery at UCSF. The procedure was performed in an MR scanner using a cutting-edge interventional technique.

UCSF offers PET/MRI technology with state-of-the-art, highly sensitive detectors for less radiation dose to our patients. By combining these two innovative tools, we are able to achieve optimal imaging for detecting early stages of abnormal cell growth